aluates Reports

$ 0.0

Automative

Global Chronic Kidney Disease (CKD) Market Research Report 2025

Published Date: 2025-09-08

Report Code: QYRE-Auto-6Q3238

Global Chronic Kidney Disease CKD Market Insights and Forecast to 2028

BUY CHAPTERS

Global Chronic Kidney Disease (CKD) Market Research Report 2025

Code: QYRE-Auto-6Q3238

Report

2025-09-08

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Allergan plc

Amgen Inc

Astrazeneca plc

Roche

FibroGen Inc

Keryx

Kissei

Pfizer Inc

Sanofi

TEVA

GlaxoSmithKline

GlaxoSmithKline PLC

Johnson & Johnson

Chronic Kidney Disease (CKD) Market Size

The global market for Chronic Kidney Disease (CKD) was valued at US$ 94610 million in the year 2024 and is projected to reach a revised size of US$ 118610 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Chronic Kidney Disease (CKD) Market

Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory condition characterized by persistent airflow limitation that makes it difficult to breathe. COPD encompasses a group of diseases, with the most common being emphysema and chronic bronchitis.

Emphysema involves the destruction of the air sacs in the lungs, while chronic bronchitis is marked by inflammation and narrowing of the airways. Symptoms include shortness of breath, chronic cough, excessive mucus production, wheezing, and tightness in the chest. COPD is often caused by long-term exposure to irritants, such as cigarette smoke, air pollution, and occupational dust or chemicals.

The condition is progressive and can significantly impact an individual"s quality of life. In advanced stages, COPD can result in severe respiratory complications and exacerbations, potentially leading to hospitalizations.

Treatment for COPD typically involves a combination of medication, pulmonary rehabilitation, oxygen therapy, and in severe cases, surgical intervention such as lung volume reduction surgery or lung transplantation. Quitting smoking, avoiding lung irritants, and getting vaccinations to prevent respiratory infections are also essential components of COPD management.

COPD is a major public health concern globally, as it can cause significant morbidity and mortality. Early diagnosis, proper management, and lifestyle modifications are critical for maintaining the respiratory function and improving the well-being of individuals living with COPD.

This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease (CKD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease (CKD).

The Chronic Kidney Disease (CKD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Kidney Disease (CKD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Kidney Disease (CKD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Kidney Disease (CKD) Market Report

Report Metric	Details
Report Name	Chronic Kidney Disease (CKD) Market
Accounted market size in year	US$ 94610 million
Forecasted market size in 2031	US$ 118610 million
CAGR	3.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	ACE Inhibitors Calcium Channel Blockers Beta Blockers Others
Segment by Application	Hospitals Specialty Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson, Keryx, Kissei, Pfizer, Sanofi, Teva
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Kidney Disease (CKD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chronic Kidney Disease (CKD) Market growing?

Ans: The Chronic Kidney Disease (CKD) Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Chronic Kidney Disease (CKD) Market size in 2031?

Ans: The Chronic Kidney Disease (CKD) Market size in 2031 will be US$ 118610 million.

Who are the main players in the Chronic Kidney Disease (CKD) Market report?

Ans: The main players in the Chronic Kidney Disease (CKD) Market are AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson, Keryx, Kissei, Pfizer, Sanofi, Teva

What are the Application segmentation covered in the Chronic Kidney Disease (CKD) Market report?

Ans: The Applications covered in the Chronic Kidney Disease (CKD) Market report are Hospitals, Specialty Clinics

What are the Type segmentation covered in the Chronic Kidney Disease (CKD) Market report?

Ans: The Types covered in the Chronic Kidney Disease (CKD) Market report are ACE Inhibitors, Calcium Channel Blockers, Beta Blockers, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 ACE Inhibitors

1.2.3 Calcium Channel Blockers

1.2.4 Beta Blockers

1.2.5 Others

1.3 Market by Application

1.3.1 Global Chronic Kidney Disease (CKD) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Kidney Disease (CKD) Market Perspective (2020-2031)

2.2 Global Chronic Kidney Disease (CKD) Growth Trends by Region

2.2.1 Global Chronic Kidney Disease (CKD) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chronic Kidney Disease (CKD) Historic Market Size by Region (2020-2025)

2.2.3 Chronic Kidney Disease (CKD) Forecasted Market Size by Region (2026-2031)

2.3 Chronic Kidney Disease (CKD) Market Dynamics

2.3.1 Chronic Kidney Disease (CKD) Industry Trends

2.3.2 Chronic Kidney Disease (CKD) Market Drivers

2.3.3 Chronic Kidney Disease (CKD) Market Challenges

2.3.4 Chronic Kidney Disease (CKD) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue

3.1.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue (2020-2025)

3.1.2 Global Chronic Kidney Disease (CKD) Revenue Market Share by Players (2020-2025)

3.2 Global Chronic Kidney Disease (CKD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chronic Kidney Disease (CKD) Revenue

3.4 Global Chronic Kidney Disease (CKD) Market Concentration Ratio

3.4.1 Global Chronic Kidney Disease (CKD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Revenue in 2024

3.5 Global Key Players of Chronic Kidney Disease (CKD) Head office and Area Served

3.6 Global Key Players of Chronic Kidney Disease (CKD), Product and Application

3.7 Global Key Players of Chronic Kidney Disease (CKD), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Kidney Disease (CKD) Breakdown Data by Type

4.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Type (2020-2025)

4.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2026-2031)

5 Chronic Kidney Disease (CKD) Breakdown Data by Application

5.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Application (2020-2025)

5.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chronic Kidney Disease (CKD) Market Size (2020-2031)

6.2 North America Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chronic Kidney Disease (CKD) Market Size by Country (2020-2025)

6.4 North America Chronic Kidney Disease (CKD) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Kidney Disease (CKD) Market Size (2020-2031)

7.2 Europe Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chronic Kidney Disease (CKD) Market Size by Country (2020-2025)

7.4 Europe Chronic Kidney Disease (CKD) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size (2020-2031)

8.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2020-2025)

8.4 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Kidney Disease (CKD) Market Size (2020-2031)

9.2 Latin America Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2020-2025)

9.4 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size (2020-2031)

10.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2020-2025)

10.4 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Chronic Kidney Disease (CKD) Introduction

11.1.4 AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Chronic Kidney Disease (CKD) Introduction

11.2.4 Allergan Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.2.5 Allergan Recent Development

11.3 Amgen

11.3.1 Amgen Company Details

11.3.2 Amgen Business Overview

11.3.3 Amgen Chronic Kidney Disease (CKD) Introduction

11.3.4 Amgen Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.3.5 Amgen Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Chronic Kidney Disease (CKD) Introduction

11.4.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.4.5 AstraZeneca Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Chronic Kidney Disease (CKD) Introduction

11.5.4 Roche Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.5.5 Roche Recent Development

11.6 FibroGen

11.6.1 FibroGen Company Details

11.6.2 FibroGen Business Overview

11.6.3 FibroGen Chronic Kidney Disease (CKD) Introduction

11.6.4 FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.6.5 FibroGen Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Introduction

11.7.4 GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.7.5 GlaxoSmithKline Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Details

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Introduction

11.8.4 Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.8.5 Johnson & Johnson Recent Development

11.9 Keryx

11.9.1 Keryx Company Details

11.9.2 Keryx Business Overview

11.9.3 Keryx Chronic Kidney Disease (CKD) Introduction

11.9.4 Keryx Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.9.5 Keryx Recent Development

11.10 Kissei

11.10.1 Kissei Company Details

11.10.2 Kissei Business Overview

11.10.3 Kissei Chronic Kidney Disease (CKD) Introduction

11.10.4 Kissei Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.10.5 Kissei Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Details

11.11.2 Pfizer Business Overview

11.11.3 Pfizer Chronic Kidney Disease (CKD) Introduction

11.11.4 Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.11.5 Pfizer Recent Development

11.12 Sanofi

11.12.1 Sanofi Company Details

11.12.2 Sanofi Business Overview

11.12.3 Sanofi Chronic Kidney Disease (CKD) Introduction

11.12.4 Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.12.5 Sanofi Recent Development

11.13 Teva

11.13.1 Teva Company Details

11.13.2 Teva Business Overview

11.13.3 Teva Chronic Kidney Disease (CKD) Introduction

11.13.4 Teva Revenue in Chronic Kidney Disease (CKD) Business (2020-2025)

11.13.5 Teva Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Allergan plc

Amgen Inc

Astrazeneca plc

Roche

FibroGen Inc

Keryx

Kissei

Pfizer Inc

Sanofi

TEVA

GlaxoSmithKline

GlaxoSmithKline PLC

Johnson & Johnson

List of Tables

Table 1. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of ACE Inhibitors

Table 3. Key Players of Calcium Channel Blockers

Table 4. Key Players of Beta Blockers

Table 5. Key Players of Others

Table 6. Global Chronic Kidney Disease (CKD) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Chronic Kidney Disease (CKD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Chronic Kidney Disease (CKD) Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Chronic Kidney Disease (CKD) Market Share by Region (2020-2025)

Table 10. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Chronic Kidney Disease (CKD) Market Share by Region (2026-2031)

Table 12. Chronic Kidney Disease (CKD) Market Trends

Table 13. Chronic Kidney Disease (CKD) Market Drivers

Table 14. Chronic Kidney Disease (CKD) Market Challenges

Table 15. Chronic Kidney Disease (CKD) Market Restraints

Table 16. Global Chronic Kidney Disease (CKD) Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Chronic Kidney Disease (CKD) Market Share by Players (2020-2025)

Table 18. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) as of 2024)

Table 19. Ranking of Global Top Chronic Kidney Disease (CKD) Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Chronic Kidney Disease (CKD), Headquarters and Area Served

Table 22. Global Key Players of Chronic Kidney Disease (CKD), Product and Application

Table 23. Global Key Players of Chronic Kidney Disease (CKD), Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Chronic Kidney Disease (CKD) Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2020-2025)

Table 27. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2026-2031)

Table 29. Global Chronic Kidney Disease (CKD) Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2020-2025)

Table 31. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2026-2031)

Table 33. North America Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Chronic Kidney Disease (CKD) Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Chronic Kidney Disease (CKD) Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Chronic Kidney Disease (CKD) Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Chronic Kidney Disease (CKD) Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Chronic Kidney Disease (CKD) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2026-2031) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Chronic Kidney Disease (CKD) Product

Table 51. AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Allergan Company Details

Table 54. Allergan Business Overview

Table 55. Allergan Chronic Kidney Disease (CKD) Product

Table 56. Allergan Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 57. Allergan Recent Development

Table 58. Amgen Company Details

Table 59. Amgen Business Overview

Table 60. Amgen Chronic Kidney Disease (CKD) Product

Table 61. Amgen Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 62. Amgen Recent Development

Table 63. AstraZeneca Company Details

Table 64. AstraZeneca Business Overview

Table 65. AstraZeneca Chronic Kidney Disease (CKD) Product

Table 66. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 67. AstraZeneca Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Chronic Kidney Disease (CKD) Product

Table 71. Roche Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 72. Roche Recent Development

Table 73. FibroGen Company Details

Table 74. FibroGen Business Overview

Table 75. FibroGen Chronic Kidney Disease (CKD) Product

Table 76. FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 77. FibroGen Recent Development

Table 78. GlaxoSmithKline Company Details

Table 79. GlaxoSmithKline Business Overview

Table 80. GlaxoSmithKline Chronic Kidney Disease (CKD) Product

Table 81. GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 82. GlaxoSmithKline Recent Development

Table 83. Johnson & Johnson Company Details

Table 84. Johnson & Johnson Business Overview

Table 85. Johnson & Johnson Chronic Kidney Disease (CKD) Product

Table 86. Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 87. Johnson & Johnson Recent Development

Table 88. Keryx Company Details

Table 89. Keryx Business Overview

Table 90. Keryx Chronic Kidney Disease (CKD) Product

Table 91. Keryx Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 92. Keryx Recent Development

Table 93. Kissei Company Details

Table 94. Kissei Business Overview

Table 95. Kissei Chronic Kidney Disease (CKD) Product

Table 96. Kissei Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 97. Kissei Recent Development

Table 98. Pfizer Company Details

Table 99. Pfizer Business Overview

Table 100. Pfizer Chronic Kidney Disease (CKD) Product

Table 101. Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 102. Pfizer Recent Development

Table 103. Sanofi Company Details

Table 104. Sanofi Business Overview

Table 105. Sanofi Chronic Kidney Disease (CKD) Product

Table 106. Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 107. Sanofi Recent Development

Table 108. Teva Company Details

Table 109. Teva Business Overview

Table 110. Teva Chronic Kidney Disease (CKD) Product

Table 111. Teva Revenue in Chronic Kidney Disease (CKD) Business (2020-2025) & (US$ Million)

Table 112. Teva Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Chronic Kidney Disease (CKD) Picture

Figure 2. Global Chronic Kidney Disease (CKD) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Kidney Disease (CKD) Market Share by Type: 2024 VS 2031

Figure 4. ACE Inhibitors Features

Figure 5. Calcium Channel Blockers Features

Figure 6. Beta Blockers Features

Figure 7. Others Features

Figure 8. Global Chronic Kidney Disease (CKD) Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Chronic Kidney Disease (CKD) Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Specialty Clinics Case Studies

Figure 12. Chronic Kidney Disease (CKD) Report Years Considered

Figure 13. Global Chronic Kidney Disease (CKD) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Chronic Kidney Disease (CKD) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Chronic Kidney Disease (CKD) Market Share by Region: 2024 VS 2031

Figure 16. Global Chronic Kidney Disease (CKD) Market Share by Players in 2024

Figure 17. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2024

Figure 19. North America Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Chronic Kidney Disease (CKD) Market Share by Country (2020-2031)

Figure 21. United States Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Chronic Kidney Disease (CKD) Market Share by Country (2020-2031)

Figure 25. Germany Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Region (2020-2031)

Figure 33. China Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Chronic Kidney Disease (CKD) Market Share by Country (2020-2031)

Figure 41. Mexico Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Country (2020-2031)

Figure 45. Turkey Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Chronic Kidney Disease (CKD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. AbbVie Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 49. Allergan Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 50. Amgen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 51. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 53. FibroGen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 55. Johnson & Johnson Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 56. Keryx Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 57. Kissei Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 58. Pfizer Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 59. Sanofi Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 60. Teva Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions